Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Vistagen Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +1 vs. Q2 2023
- Shares held
- 3.00M
- +2.03M (+209.1%) vs. Q2 2023
- Total value
- $15.7M
- +$13.9M (+766.6%) vs. Q2 2023
- New holders
- 13
- 11 more added
- Sold out
- 12
- 7 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $2.54M |
| Q1 2026 | 56 | $8.12M |
| Q4 2025 | 55 | $8.84M |
| Q3 2025 | 58 | $81.8M |
| Q2 2025 | 51 | $30.3M |
| Q1 2025 | 48 | $39.0M |
| Q4 2024 | 54 | $44.9M |
| Q3 2024 | 47 | $45.3M |
| Q2 2024 | 43 | $56.3M |
| Q1 2024 | 42 | $90.8M |
| Q4 2023 | 46 | $90.0M |
| Q3 2023 | 34 | $15.7M |
| Q2 2023 | 33 | $1.82M |
| Q1 2023 | 83 | $4.79M |
| Q4 2022 | 86 | $4.15M |
| Q3 2022 | 93 | $9.13M |
| Q2 2022 | 112 | $122.1M |
| Q1 2022 | 116 | $167.8M |
| Q4 2021 | 106 | $269.2M |
| Q3 2021 | 105 | $360.2M |
| Q2 2021 | 101 | $389.0M |
| Q1 2021 | 74 | $225.2M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Commodore Capital LP | 1,575,000 | $8.25M | 0.96% | +1,575,000 | New |
| Vanguard Group Inc | 253,715 | $1.33M | 0.00% | +29,804+13.3% | Added |
| Ikarian Capital, LLC | 229,100 | $1.20M | 0.45% | +229,100 | New |
| Schonfeld Strategic Advisors LLC | 138,500 | $725.7K | 0.01% | +138,500 | New |
| Sphera Funds Management Ltd. | 100,000 | $524.0K | 0.13% | +100,000 | New |
| BML Capital Management, LLC | 100,000 | $524.0K | 0.48% | +100,000 | New |
| BlackRock Inc. | 88,046 | $461.4K | 0.00% | −16,960−16.2% | Reduced |
| Blair William & Co | 85,173 | $446.3K | 0.00% | +85,173 | New |
| Group One Trading, L.P. | 75,305 | $394.6K | 0.02% | +72,913+3,048.2% | Added |
| Geode Capital Management, LLC | 73,164 | $383.5K | 0.00% | +15,842+27.6% | Added |
| MYDA Advisors LLC | 50,000 | $262.0K | 0.10% | +50,000 | New |
| Boothbay Fund Management, LLC | 46,895 | $245.7K | 0.01% | +46,895 | New |
| Gsa Capital Partners LLP | 46,782 | $245.0K | 0.02% | −152,034−76.5% | Reduced |
| State Street Corp | 25,464 | $133.4K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 20,200 | $105.8K | 0.01% | +20,200 | New |
| Susquehanna International Group, LLP | 19,355 | $101.4K | 0.00% | +7,053+57.3% | Added |
| Millennium Management LLC | 16,870 | $88.4K | 0.00% | −84,200−83.3% | Reduced |
| Northern Trust Corp | 14,524 | $76.1K | 0.00% | +4,171+40.3% | Added |
| Raymond James & Associates | 10,000 | $52.4K | 0.00% | +10,000 | New |
| Citadel Advisors LLC | 8,552 | $44.8K | 0.00% | −11,319−57.0% | Reduced |
| GPS Wealth Strategies Group, LLC | 8,441 | $44.2K | 0.01% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 4,813 | $25.2K | 0.00% | +3,668+320.3% | Added |
| Royal Bank of Canada | 2,860 | $15.0K | 0.00% | +2,711+1,819.5% | Added |
| Morgan Stanley | 2,560 | $13.4K | 0.00% | −860−25.1% | Reduced |
| CWM, LLC | 2,449 | $13.0K | 0.00% | −1,333−35.2% | Reduced |
| Simplex Trading, LLC | 2,464 | $12.0K | 0.00% | +1,518+160.5% | Added |
| UBS Group AG | 1,498 | $7.85K | 0.00% | +1,381+1,180.3% | Added |
| Qube Research & Technologies Ltd | 1,192 | $6.25K | 0.00% | +1,192 | New |
| Bank of America Corp | 633 | $3.32K | 0.00% | +1+0.2% | Added |
| EverSource Wealth Advisors, LLC | 88 | $461 | 0.00% | +88 | New |
| Wells Fargo & Company | 68 | $356 | 0.00% | +28+70.0% | Added |
| Toronto Dominion Bank | 46 | $241 | 0.00% | +46 | New |
| Citigroup Inc | 41 | $214 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 16 | $84 | 0.00% | −465−96.7% | Reduced |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −57,316−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −47,696−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −41,363−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −30,225−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −7,720−100.0% | Sold out |
| Performa Ltd (US), LLC | 0 | $0 | 0.00% | −4,900−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −4,393−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1,936−100.0% | Sold out |
| Twin Lakes Capital Management, LLC | 0 | $0 | 0.00% | −416−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −83−100.0% | Sold out |